X Wang, M M Hu, J Y Xiao, Z H Lin, T T Shi, X F Li, H Y Qiu
{"title":"[达拉单抗治疗异基因造血干细胞移植后复发的T细胞急性淋巴细胞白血病:病例报告]。","authors":"X Wang, M M Hu, J Y Xiao, Z H Lin, T T Shi, X F Li, H Y Qiu","doi":"10.3760/cma.j.cn121090-20231130-00285","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":24016,"journal":{"name":"Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi","volume":"45 7","pages":"698"},"PeriodicalIF":0.0000,"publicationDate":"2024-07-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11388128/pdf/","citationCount":"0","resultStr":"{\"title\":\"[Daratumumab for the treatment of relapsed T-cell acute lymphoblastic leukemia after allogeneic hematopoietic stem cell transplantation: a case report].\",\"authors\":\"X Wang, M M Hu, J Y Xiao, Z H Lin, T T Shi, X F Li, H Y Qiu\",\"doi\":\"10.3760/cma.j.cn121090-20231130-00285\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\",\"PeriodicalId\":24016,\"journal\":{\"name\":\"Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi\",\"volume\":\"45 7\",\"pages\":\"698\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2024-07-14\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11388128/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.3760/cma.j.cn121090-20231130-00285\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q3\",\"JCRName\":\"Medicine\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.3760/cma.j.cn121090-20231130-00285","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"Medicine","Score":null,"Total":0}
[Daratumumab for the treatment of relapsed T-cell acute lymphoblastic leukemia after allogeneic hematopoietic stem cell transplantation: a case report].